Published March 20, 2015 | Version v1
Journal article Open

Sarkopenie und Frailty in der Neurologie. [Sarcopenia and frailty in neurology; Article in German].

  • 1. Neurologie mit Schwerpunkt Neurodegeneration, Hertie Institut für klinische Hirnforschung, Universitätsklinikum Tübingen and Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE), Tübingen
  • 2. Medizinische Klinik und Poliklinik IV, Schwerpunkt Akutgeriatrie, Klinikum der Universität München (LMU)
  • 3. Klinik für Geriatrie mit Neurologie und Tagesklinik, Johanniter-Krankenhaus Bonn and European Institute for Molecular Imaging (EIMI), Westfälische Wilhelms Universität (WWU), Münster

Description

Sarcopenia and frailty are common geriatric syndromes and are associated with adverse health outcome and impaired health-related quality of life. Co-occurrences of these two syndromes with age-related neurological diseases are potentially high but not well investigated. Moreover, it is not well understood how these syndromes interact with neurological diseases, such as Parkinson's disease, Alzheimer's disease and stroke. This article introduces the currently most accepted concepts of sarcopenia and frailty, discusses the potential relevance of the syndromes for geriatric patients and presents examples of studies that investigated potential interactions between these geriatric and neurological syndromes and conditions. First results indicate that (i) the co-occurrence of these geriatric syndromes and age-related neurological diseases is high, (ii) sarcopenia and frailty can influence the clinical state of neurological diseases to a relevant extent and (iii) at least some common causes and pathophysiological processes confer the geriatric and neurological conditions. In conclusion, profound knowledge about the interaction of sarcopenia, frailty and age-associated neurological conditions is currently not available. Such knowledge would have an enormous potential for improved therapy of these neurological conditions.

Files

Maetzler_Nervenarzt_2015-P01-AAM.pdf

Files (1.5 MB)

Name Size Download all
md5:f768e537274185f8962b8cef7f115fe6
1.5 MB Preview Download

Additional details

Funding

INMIND – Imaging of Neuroinflammation in Neurodegenerative Diseases 278850
European Commission